Nitto Avecia
Milford, MA, United States avecia.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Nitto Avecia develops and manufactures oligonucleotide therapeutics for pharmaceutical companies, from preclinical work through commercial supply. It operates facilities in Milford, Massachusetts, and Cincinnati, Ohio, serving customers with development, manufacturing, analytical, and quality support.
Services
Preclinical Manufacturing
Provides custom preclinical oligonucleotide manufacturing through the OliGrow® service for non-cGMP applications.
Analytical Development
Develops, qualifies, and validates analytical methods for raw materials, intermediates, and final product, including support for ICH stability studies.
Process Development
Develops and validates oligonucleotide processes and supports onboarding risk assessments, scale-up, specification development, and raw material qualification.
Drug Substance Manufacturing
Manufactures oligonucleotide drug substance from preclinical quantities to commercial supply.
Process Performance Qualification
Develops and executes PPQ programs for oligonucleotide manufacturing.
Quality Control/Stability
Provides study design, comprehensive testing services, and sample storage conditions for quality control and stability work.
Capabilities
- Assays and studies
- Oligonucleotides
- Analytical development
- Process development
- Stability studies
- CRISPR
- Analytical method development
8 more
- Method transfer
- Method validation
- Impurity testing
- Sequencing
- Environmental monitoring
- Raw material analysis
- In-process analysis
- Final product analysis
- Scale and capacity
- Batch sizes from 100 mg to 25 g
- Batches from a few mmol up to 1600 mmol
- First 50 mg of preclinical material
- Hundreds of kilograms in commercial supply
- Multiple cGMP manufacturing trains
- ISO8-qualified, HEPA-filtered manufacturing suites
Instruments and platforms
- LC-ESI-MS/MS
- HRAMS
Modalities and species
- Modalities
- Oligonucleotide
- Gene editing
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
As listed: GMP-compliant; cGMP requirements of 21 CFR Part 210 and
FDA registrationSelf-reported
Details
- Type
- CRDMO
- Address
- 125 Fortune Boulevard Milford, MA 01757
- Sites
- Cincinnati, United States
- Serves
- Global
Public records
- FDA drug establishment registration
- 3000215431 · API MANUFACTURE source